» Articles » PMID: 25637582

Interaction of Fenoterol Stereoisomers with β2-adrenoceptor-G Sα Fusion Proteins: Antagonist and Agonist Competition Binding

Overview
Specialty Pharmacology
Date 2015 Feb 1
PMID 25637582
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The specific interaction between G-protein-coupled receptors and ligand is the starting point for downstream signaling. Fenoterol stereoisomers were successfully used to probe ligand-specific activation (functional selectivity) of the β2-adrenoceptor (β2AR) (Reinartz et al. 2015). In the present study, we extended the pharmacological profile of fenoterol stereoisomers using β2AR-Gsα fusion proteins in agonist and antagonist competition binding assays. Dissociations between binding affinities and effector potencies were found for (R,S')- and (S,S')-isomers of 4'-methoxy-1-naphthyl-fenoterol. Our data corroborate former studies on the importance of the aminoalkyl moiety of fenoterol derivatives for functional selectivity.

Citing Articles

β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and....

Ghali G, Ghali M Mol Biol Rep. 2020; 47(6):4631-4650.

PMID: 32303958 PMC: 7165076. DOI: 10.1007/s11033-020-05427-1.


Naunyn-Schmiedeberg's Archives of Pharmacology under new editorship: change and continuity.

Seifert R Naunyn Schmiedebergs Arch Pharmacol. 2016; 389(7):667-70.

PMID: 27222234 DOI: 10.1007/s00210-016-1261-3.


Recruitment of β-arrestin 1 and 2 to the β2-adrenoceptor: analysis of 65 ligands.

Littmann T, Gottle M, Reinartz M, Kalble S, Wainer I, Ozawa T J Pharmacol Exp Ther. 2015; 355(2):183-90.

PMID: 26306764 PMC: 4631950. DOI: 10.1124/jpet.115.227959.

References
1.
Woo A, Wang T, Zeng X, Zhu W, Abernethy D, Wainer I . Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes. Mol Pharmacol. 2008; 75(1):158-65. PMC: 2654765. DOI: 10.1124/mol.108.051078. View

2.
Reinartz M, Kalble S, Littmann T, Ozawa T, Dove S, Kaever V . Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol. 2014; 388(1):51-65. DOI: 10.1007/s00210-014-1054-5. View

3.
Kenakin T . What is pharmacological 'affinity'? Relevance to biased agonism and antagonism. Trends Pharmacol Sci. 2014; 35(9):434-41. DOI: 10.1016/j.tips.2014.06.003. View

4.
Plazinska A, Pajak K, Rutkowska E, Jimenez L, Kozocas J, Koolpe G . Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the β₂-adrenergic receptor. Bioorg Med Chem. 2013; 22(1):234-46. PMC: 3908673. DOI: 10.1016/j.bmc.2013.11.030. View

5.
Jozwiak K, Khalid C, Tanga M, Berzetei-Gurske I, Jimenez L, Kozocas J . Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor. J Med Chem. 2007; 50(12):2903-15. DOI: 10.1021/jm070030d. View